About Quanticel

About Quanticel

The Quanticel team combines a veteran management team, leading academics from Stanford University, and astute VC investors from Versant Ventures.

Learn More

Science and Technology

Science and Technology

Quanticel's proprietary platform for single-cell genomic analysis of tumors supports the discovery of first-in-class oncology drug candidates.

Learn More

News

News

Quanticel is engaged in a R&D collaboration with Celgene Corporation in which Quanticel will identify predictive biomarkers for Celgene’s drugs and develop novel oncology products.

Learn More

Careers

Careers

Quanticel is currently hiring exceptional researchers and technical experts committed to advancing our capabilities and, ultimately, improving patients’ lives.

Learn More